Monensin is a monocarboxylic sodium ionophore which causes increased myocardial contractility and increased coronary blood flow in the anesthetized dog. The current experiment investigated the mechanism by which monensin produces relaxation of smooth muscle from the canine coronary artery. Helical strips of coronary artery were mounted in a muscle chamber and made to contract by stimulation with 5-hydroxytryptamine. First, concentration-response curves were established for the relaxant effect of added monensin. Then the following agents were evaluated for their effects on the monensin-induced inhibition of contraction to 5-hydroxytryptamine: aminophylline, indomethacin, propranolol, ouabain, and a potassium-free solution. Finally, the effect of added monensin on potassium-induced relaxation of denervated coronary artery strips was used to further characterize this relaxant effect. The results demonstrate that monensin causes coronary smooth muscle relaxation at the same concentrations reported to cause a positive inotropic effect in isolated myocardial preparations. The monensin-induced inhibition of contraction of the isolated coronary artery was not blocked by aminophylline, propranolol, or indomethacin, demonstrating that the inhibition is not mediated by adenosine, by /3-adrenergic receptors, or by prostaglandins. The inhibition of coronary smooth muscle contraction was completely blocked by ouabain or by a potassium-free solution. Monensin also potentiated potassiuminduced relaxation of both innervated and denervated coronary artery strips; both the potassiuminduced relaxation and the potentiation of this relaxation by monensin were ouabain-blocked. We conclude that monensin produces coronary relaxation by stimulation of Na + ,K + -ATPase. This stimulation may result from a monensin-induced increase in intracellular sodium ion concentration similar to the change that, paradoxically, mediates the positive inotropic effect in the myocardium. (CircRes 53: 168-175, 1983) 
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The current experiment was designed to characterize the relaxant action of monensin on isolated coronary artery strips from dogs, and to determine the mechanisms responsible for this relaxation. Monensin itself, or knowledge of the mechanisms by which it elicits this coronary smooth muscle relaxation, might be used in treating myocardial infarction or angina resulting from coronary artery spasm.
Concentration-response curves of the dog coronary artery to monensin were determined, and the effects of the following agents on the relaxant action of monensin were investigated: aminophylline (an adenosine inhibitor), indomethacin (a prostaglandin synthesis inhibitor), propranolol (a (8-adrenergic an-tagonist), ouabain, and potassium-free solution (the latter two interventions inhibit Na + ,K + -ATPase activity). In addition, changes in the magnitude of potassium-induced relaxation of coronary arteries denervated with 6-hydroxydopamine (6-OHDA) were used as an indicator of the effect of monensin on Na + ,K + -ATPase. The results suggest that the concentration-dependent, monensin-induced relaxation of the dog coronary artery is due to increased activity of Na + ,K + -ATPase. This enzyme drives an electrogenic pump which causes membrane hyperpolarization and thereby decreases excitability of vascular smooth muscle (Bonaccorsi et al., 1977a; Webb and Bohr, 1978) .
Methods
Mongrel dogs (15-30 kg) of either sex were anesthetized with sodium pentobarbital (25 mg/kg). A section of the heart, defined by the anterior interventricular groove and containing the left anterior descending coronary artery (LAD), was excised and placed in cold physiological salt solution (PSS, composition below). The proximal end of the LAD (1.6-3.0 mm o.d.) was removed from the myocardial tissue. Adherent fat and connective tissue were then dissected away. Helical strips (1.0 X 10.0 mm) were cut from the artery and a length of 6-0 surgical silk was tied to each end. The strips were mounted vertically in a 50-ml tissue bath. One end was attached to an overhead Grass FT.03C force displacement transducer; the other end was secured to a glass rod support below. Isometric force was monitored continuously by a Grass polygraph.
The PSS was of the following composition (mu): NaCl, 130; NaHCOj, 14.9; dextrose, 5.5; KC1, 4.7; CaCl 2 2H 2 O, 1.6; KHzPO*, 1.18; MgSo, 7H 2 O, 1.17; and CaNa 2 -EDTA 0.026. It was maintained at 38°C and was aerated with 95% O 2 and 5% CO 2 , resulting in a pH of 7.4. During the equilibration period of 2 hours (PSS replaced at least every one-half hour), the strip was stretched by a 2-g force. At this passive stretch, the coronary smooth muscle developed its maximal active force. Experimentation began after establishing that contractions in response to 10" 7 M 5hydroxytryptamine (5-HT, serotonin) were reproducible.
Monensin (Calbiochem-Behring) was dissolved in ethanol at a concentration of 10~3 M and serially diluted with water. Aminophylline (Sigma Chemical Corp.), 5hydroxytryptamine creatinine sulfate (serotonin, Sigma), nirroprusside (Nipride, Roche Laboratories), ouabain octahydrate (Sigma), propranolol (Inderal, Ayerst Laboratories), and prostaglandin F^ (tris salt, Sigma) each were dissolved in water. Six-hydroxydopamine hydrobromide (300 Mg/ml, Sigma) was dissolved in bicarbonate-free PSS and used as a denervating agent according to the method of Aprigliano and Hermsmeyer (1976) . Coronary artery strips denervated in this manner were also allowed to equilibrate at least 2 hours before experimentation began. Indomethacin (Sigma) was dissolved in ethanol. Potassium-free PSS was prepared without addition of potassium chloride and by equimolar substitution of NaH 2 PC>4 for KH2PO4. All chemicals used in the PSS were of reagent grade. Drugs were diluted so that 25-150 ii\ additions by microliter syringe to the bath yielded the desired concentration. Cumulative additions did not exceed 1.0 ml in the 50-ml bath.
Data are presented as the mean ± SE of the mean of responses from the indicated number of dogs. Significance was determined by the unpaired f-test, with P < 0.05 considered significant.
Results

Concentration-Response to Monensin
Concentration-response curves to 5-HT of the LAD demonstrated that a concentration of 10~8 M caused 20% of maximum contraction (ED 2 o), with 10~7 M and 3 X 10~7 M causing EC50 and ECM contractions, respectively.
A concentration-response curve to monensin was derived by observing the effect of incubation with monensin on a 5-HT contraction (Fig. 1) . A control response was first obtained to an EC50 dose of 5-HT. After rinsing for 20 minutes (PSS replaced at least three times), a dose of monensin or the corresponding vehicle was added and allowed to incubate for 15 minutes. The EC 50 dose of 5-HT was then repeated to determine the effect of the presence of monensin on this response. The strips were again rinsed for 20 minutes, and a final EC 50 dose of 5-HT was added to assess degree of recovery of the response. Only the results from those experiments, in which the recovery response was at least 80% of the control response, are presented here. Results are presented in Figure 2 where the monensin-induced inhibition of contraction is expressed as a percent of the first control 5-HT response. A significant depression of the 5-HT response with monensin, as compared to the ethanol vehicle, occurred at monensin concentrations 5.6 X 10~7 M and greater. Seventeen of 33 strips preincubated with 10~6 M monensin recovered to at least 80% of the control response. Strips preincubated with 10~5 M monensin did not recover after rinsing for 20 minutes, and therefore are not included in these data. A slight inhibition of the 5-HT contraction was observed with the ethanol vehicle at concentrations less than 0.3%. At 0.3% ethanol in the bath, potentiation of the 5-HT contraction was observed. We have also investigated the effect of monensin on the dog coronary artery, precontracted with 5-HT (Figs. 3 and 4). Monensin causes relaxation of this contractile response. Cumulative additions of monensin resulted in a concentration-dependent relaxation; the threshold concentration for this relaxation was 10~7 M monensin. The relaxation was prevented by 10~* M ouabain. In these experiments, contractile responses to 10~7 M 5-HT in the presence and absence of the 10~6 M ouabain were 554 ± 35 mg {n = 7) and 474 ± 53 mg {n = 7), respectively. The magnitude of force development in response to 10~7 M 5-HT before addition of the vehicle was 569 ± 57 mg (n = 7).
Effect of Inhibitors
To investigate the mechanisms of action of monensin on the dog LAD, the effects of the following h-20 mm FIGURE 1. Protocol for "single-dose" monensm or vehicle concentration-response determinations. This is a representative polygraph tracing of the procedure used in "single-dose" experiments. The vessel was stimulated with 10~7 vCEQa) 5-HT (contraction A), and then rinsed three times with PSS during a 20-mmute period. Then, a dose of monensin or the appropriate vehicle was added and allowed to incubate for 15 minutes, after which, 5-HT was again added (contraction B). The vessel was then again rinsed three times during a 20-minute period. The vessel was stimulated with 5-HT a third time to assess recovery (contraction Q. Percent control response equals force of contraction in B divided by that in A x 200. Recovery equals the force of contraction in C divided by that in A x 100. "R" indicates a "nnse," where the PSS in the bath was replaced. The results are summarized m Figure Z blocking agents were evaluated for their ability to alter the inhibitory effect of monensin: aminophylline (10~5 M), indomethacin (5 jig/ml), ouabain (10 M), K + -free PSS or propranolol (5 X 10~7 M). These concentrations were selected because they are known to block the vasodilator activity of endogenous adenosine, cycloxygenase products (prostaglandins), and /9-adrenergic activation. A 10~6 M inhibiting dose of monensin was used in conjunction with an EC 50 5HT contraction as in the procedure of Figure 1 . The vessels were incubated at least 30 minutes before and then continuously during the . Concentration-response of dog coronary artery to "singledose" monensin in the ethanol/water vehicle or vehicle alone. Vessels were incubated with monensin or vehicle for 15 minutes before the addition of 5-HT (ECx). This response then was compared to that of control. "Percent control response to 5-HT " values are each the mean ± SEM of the number of dogs indicated in parentheses. Asterisk indicates significant difference from vehicle control, P < 0.05. study with aminophylline, indomethacin, ouabain, or propranolol ("continuous' method).
A slightly different protocol was used in the K +free PSS experiments and in two of the five ouabain experiments. In this protocol ('intermittent'), K + -free PSS replaced the PSS in the bath 5 minutes before and remained in the bath during the incubation with 1CT 6 M monensin and the associated 5-HT contraction (Fig. 5) . The control and recovery responses were similarly conducted with K + -free PSS or ouabain present 5 minutes before and during these 5-HT contractions. This procedure was used to minimize the catecholamine releasing action of a K + -free solution (Bonaccorsi et al., 1977b) . It should be noted that there is variability in the absolute forces developed by different coronary artery strips in response to 10~7 M 5-HT (compare Figures 1, 3, 5, and 7) . This is attributable to differences in the sizes of the coronary arteries used and to the fact that there is a diminution in force-generating ability in a K + -free solution (Skaug and Detar, 1981) . Absolute forces generated in response to 5-HT in the presence of each of these interventions were: 0.1% ethanol vehicle, 493 ± 1 7 2 mg; monensin, 249 ± 39 mg; aminophylline, 498 ±155 mg; indomethacin, 359 ± 68 mg; ouabain, 422 ± 150 mg; K + -free PSS, 295 ± 99 mg; and propranolol, 169 ± 45 mg.
The monensin-induced inhibition of the 5-HT response was not significantly reversed in the presence of indomethacin, propranolol, or aminophylline ( Fig. 6) . However, the inhibition was greatly attenuated by K + -free PSS or ouabain. The mean 'percent control response to 5-HT' depicted for ouabain in Figure 6 (86 ± 9%, n = 5) is the mean of 'continuous' (76 ± 12%, n = 3) and 'intermittent' (100 ± 2%, n = 2) incubations of ouabain. Both types of ouabain incubation resulted in a similar reversal of the monensin-induced inhibition of the 5-HT response, so the two sets of data were pooled. In two of four vessels studied in K + -free PSS and in one of five vessels studied in 10" 5 M ouabain, the resting force increased during the preincubation with 10 6 M monensin (Fig. 5 ).
To ensure that this smooth muscle is able to relax in the presence of ouabain or K + -free PSS, the effect of NaNC>2 (10~3 M), a nonspecific relaxant of vascular smooth muscle, was studied. Vessels made to contract with 5-HT in the presence of K + -free PSS (n = 2) or ouabain (n = 4) quickly relaxed to a level of force below the precontraction resting force when NaNO 2 was added ( Fig. 5 ). This relaxation must not be dependent on the electrogenic pump which is blocked by a K + -free solution or by ouabain.
Potassium Relaxation of Denervated Coronary Artery
Finally, the effect of added monensin on potassium-induced relaxation of both innervated and denervated strips was investigated to assess changes in Na + ,K + -ATPase activity (Bonaccorsi et al., 1977a; Bohr, 1978,1981) . Strips were denervated with 6-OHDA, as described in Methods, to determine whether the monensin-induced relaxation was secondary to neurogenic effects of the agents used (Aprigliano and Hermsmeyer, 1976) .
The innervated strips and their denervated counterparts were first incubated with 1.0 nw K + PSS (Fig. 7) . After 5 minutes of incubation, 10" 7 M 5-HT (EC50) was added to cause contraction of the strips. At the 10-minute mark, 50 n\ of 2 M KC1 was added to the bath, raising the K + concentration to 3 mM. This initiated potassium-induced relaxation. Simi-
. Protocol for studying effects of aminophylline, indomethacin, ouabain, K + -free PSS, or propranolol on KT 6 M monensin inhibition of a 10~7 M 5-HT (ECx) response. This is a representative polygraph tracing of an experiment m which the strip was treated with K*-free PSS 5 minutes before and dunng the stimulation with 5-HT (contraction A), the pretreatment with monensin and subsequent 5-HT stimulation (contraction B), and the recovery response to 5-HT (contraction C). 'Intermittent" incubations with ouabain were conducted m a similar manner. Alternatively, vessels were treated "continuously" with aminophylline, indomethacin, ouabain, or propranolol in separate experiments (see text). "R" indicates a "rinse," where the PSS in the bath was replaced. When contraction B had stabilized, 1O~3 M NaNO 2 was added in order to determine the effect of a nonspecific relaxing agent on the contraction (see text). "Percent control response to 5-HT ' equals force of contraction in B divided by that in A x 100. The results are summarized in Figure 4 .
larly, potassium manipulations were studied after the addition of 1(T 6 M monensin or after the addition of 10~6 M monensin with 1CT 5 M ouabain; each of these experiments was bracketed by control relaxations to assess recovery of the strips. Twenty minutes rinse time after the monensin-only incubation, and 70 minutes rinse time after the monensin + ouabain incubation were allowed before recovery was determined. Recovery to at least 80% of the initial control relaxation was achieved by all of the strips. The results are summarized in Figure 8 . Potassium-induced relaxation of the innervated strips did not differ significantly from the denervated strips. Incubation with 10~6 M monensin significantly potentiated the relaxation induced by an increase in extracellular potassium. This potentiation of relaxation was completely abolished and reversed in the presence of 10~5 M ouabain; likewise, the relaxation of the 5-HT contraction produced by the increased extracellular potassium alone was reversed by 10~5 M ouabain. Before the addition of 5-HT, an increase in resting force was observed in five of eight strips incubated with monensin and ouabain (Fig. 7) .
Discussion
Several investigators have reported that the sodium ionophore monensin causes coronary vasodilation and positive inotropy in the anesthetized dog Saini et al., 1979) . Attempts to understand the mechanism responsible for this dilation of the dog coronary artery have not given successful results. The current study is, to our knowledge, the first characterization of the relaxant effect of monensin on the isolated coronary artery from the dog. A precipitous, monensin-induced relaxation of strips of the dog LAD occurred at bath concentrations of 5.6 x 10~7 M or greater. This concentration approximates the 10~7 to 3 X 10~5 M range in which monensin is pharmacologically active on the myocardium, producing a positive inotropic effect (Sutko et al., 1977; Shlafer et al., 1978; Shlafer and Kane, 1980) . At monensin concentrations greater than 3 x 10" 5 M, contracture and/or arrhythmia develop in isolated heart preparations. At a similar concentration of monensin (10 M), the dog LAD did not recover after 20 minutes of rinsing.
The current observations demonstrate that neither adenosine (Berne, 1980) nor prostaglandin release (Afonso et al., 1974 ) play a significant role in mo-FIGURE 7. Protocol for studying effects of monensin on potassium-induced relaxation in dog coronary artery strips. This is a representative polygraph tracing of an experiment in which the effects of monensin and monensin + ouabain were studied on a 6-OHDA-denervated vessel. In contraction-relaxation A, the vessel was incubated with 1.0 m/sK* PSS for 5 minutes, at which time 10~7 M 5HT (ECyJ was added to contract the vessel. At least 5 minutes were allowed for the contraction to stabilize. KCI was added to raise the bath potassium concentration to 3 muand thus initiate relaxation. The protocol was identical to this for contraction-relaxations B and C, except 1CT 6 M monensin and 10~' M ouabain with 1CT* Mmonensin, respectively, were added after the bath had been replaced with 1.0 muK* PSS. "R" indicates a "rinse," in which bath PSS was replaced. 'Percent relaxation of EC K 5-HT contraction" equals the change in magnitude of the force after raising the bath K + concentration to 3 itiw divided by the force of contraction generated by the 5-HT x 100. Contraction-relaxations B and C were bracketed by a potassium-induced relaxation (not shown). These were conducted as contraction-relaxation A and used to assess recovery (see text). The results are summarized in Figure 6 .
nensin-induced coronary relaxation. Blockade of adenosine with aminophylline and of prostaglandin synthesis with indomethacin in this experiment failed to alter the coronary artery relaxation produced by monensin.
Several reports indicate that monensin causes the release of endogenous catecholamines in myocardial tissue and that this may be, in part, responsible for its positive inotropic effect Sutko et al., 1977; Shlafer et al., 1978; Saini et al., 1979) . In Figure 6 , the data suggest that /J-adrenergic blockade does not reduce the inhibitory effects of monensin. In the presence of propranolol, catecholamines released from adrenergic nerve endings in response to addition of monensin would activate only a-adrenergic receptors (Zuberbuhler and Bohr, 1965) and, thereby, diminish the major component of the monensin relaxation caused by /3receptor activation. Furthermore, the persistence of a potentiation in potassium-induced relaxation with added monensin in the denervated coronary artery strips ( Figs. 7 and 8) demonstrates that norepinephrine release by intrinsic nerve terminals is not a basis for this relaxation. Porquet et al. (1982) have demonstrated that 5-HT does not cause endogenous catecholamine release nor, itself, directly activate a-adrenergic receptors in the proximal portion of the dog LAD in vitro. However, 5-HT is known to activate /S-adrenergic receptors in cranial vessels of the cat and man (Edvinsson et al., 1978) . The /S-activating ability of 5-HT need be of little concern in the propranolol experiments, since propranolol was present during the control 5-HT contractions. Any 0-adrenergic effects of 5-HT would be blocked during the entire experiment, and the only variable is the presence or absence of monensin. In an attempt to eliminate adrenergic and other possible effects by the use of 5-HT as a contractile agonist, we have conducted similar experiments using PGF 2a as a contractile agonist. Incubation with 10~6 M monensin inhibited an EC 50 PGF 2a contraction just as it inhibited the 5-HT response (n = 4, unpublished observations). Thus the monensin-induced inhibition of a 5-HT contraction of the dog coronary artery can be explained neither on the basis of neuronal or adrenergic influence, nor on the basis of the choice of 5-HT as a contractile agonist.
The data in Figure 6 , showing reversal of the monensin-induced relaxation with K + -free PSS or with ouabain, strongly suggest that the primary relaxant effect of monensin is dependent on its stimulating action of Na + ,K + -ATPase. This stimulating action may be the consequence of an increased intracellular sodium concentration resulting from the action of monensin as a sodium ionophore. When present, K + -free PSS, which removes the extracellular cation necessary for pump action, and ouabain, which binds reversibly to and inhibits the pump, still permit an increase in intracellular sodium, but this sodium cannot stimulate the pump to cause hyperpolarization and the resultant coronary smooth muscle relaxation.
To test further the participation of Na + ,K + -ATPase in monensin-induced relaxation, we chose potassium-induced relaxation as an indicator for Na + ,K + -ATPase activity (Bonaccorsi et al., 1977a; Webb and Bohr, 1978) . Denervation of the dog LAD in vitro by 6-OHDA does not interfere with potassium relaxation (Bonaccorsi et al., 1977a) , and this intervention was integrated into the protocol. Incubation with 10~6 M monensin enhanced potassium-induced relaxation in both innervated and denervated strips. This confirms the hypothesis that increased electrogenie pump activity stimulated by a monensin-induced increase in intracellular sodium is responsible Figure 7 , it was found that incubation with 1O~* M monensin potentiated potassium-induced relaxation of both innervated and denervated dog coronary LAD strips Both this monensininduced potentiation of potassium-induced relaxation and the potassium-induced relaxation alone were reversed by 1O~* Mouabain. Each "percent relaxation" value is the mean ± SEM of four dogs. Asterisk indicates a significant difference in each mean of innervated or denervated preparations, P < 0.05, as compared to the respective innervated or denervated "control" potassium-induced relaxation mean. There was no significant difference (P<0 05) in the comparison of innervated and denervated means for each of the experimental interventions.
for membrane hyperpolarization and relaxation. The two interventions use the same mechanism and their effects are additive. As would be expected, ouabain reversed both the potassium-induced relaxation and the potentiation of this same relaxation by monensin. Ouabain is known to block the enhanced potassium-induced relaxation caused by agents that stimulate the electrogenic pump (Webb and Bohr, 1981) .
Similar effects of added monensin on the electrogenic pump have been observed in other experimental models. In the mouse fibroblast, monensin caused an increase in intracellular sodium, Na + ,K + -ATPase was stimulated, and the cell was hyperpolarized (Smith and Austic, 1980) . Monensin also produced a 22-mV hyperpolarization in resting membrane potential in mouse neuroblastoma-rat glioma hybrid cells (lichtshtein et al., 1979) . Ouabain blocked the hyperpolarization in both experiments. Recently Brock et al. (1982) have measured Na + ,K + -ATPase activity in rat aorta using the ouabain-sensitive ^Rb" 1 " uptake method. They found that monensin increased 86 Rb + uptake in rat aortic smooth muscle by increasing total cell sodium. In preliminary, unpublished experiments, we have ob-served that monensin causes relaxation of rat tail and coronary arteries, precontracted with norepinephrine and serotonin, respectively. These relaxation responses are blocked by ouabain and by K +free solution. These observations, along with those of Brock et al., (1982) , suggest that the results that we have observed with the dog LAD may be a generalized effect of monensin on vascular smooth muscle.
An increase in intracellular sodium concentration may also influence muscle contraction by altering the activity of a sodium-calcium exchange system (Blaustein, 1981) . This 'sodium out-calcium in' exchange would be expected to increase intracellular calcium concentration and therefore could account for the positive inorropic effect of monensin on the myocardium. The sodium-calcium exchange might also be operant in the dog coronary artery. This would explain the increase in force seen shortly after monensin administration in the K + -free PSS or ouabain-treated strips ( Figs. 5 and 7) . The increase in intracellular calcium would activate the actomyosin contractile machinery, resulting in an increased force generated by the vessel. This effect is masked by the greater influence of the electrogenic pump when monensin is administered in the absence of ouabain or potassium-free solution. Thus, paradoxical effects of a positive inotropic action by monensin on the myocardium and a relaxant effect on vascular smooth muscle could be explained by an increase in intracellular sodium concentration in both tissues. In the myocardium, sodium-calcium exchange has the dominant influence, whereas membrane hyperpolarization has the determining action on vascular smooth muscle.
In summary, the monocarboxylic sodium ionophore monensin causes relaxation of the isolated coronary artery of the dog. This effect is caused by an increase in intracellular sodium which stimulates the Na + ,K + -ATPase, resulting in membrane hyperpolarization and depressed excitability. Monensin therefore has the interesting properties of being a direct-acting coronary dilator while having a positive inotropic effect on the myocardium.
